Literature DB >> 27363342

Discovery of pathogenic variants in a large Korean cohort of inherited muscular disorders.

H J Park1,2, H Jang3, J H Kim4, J H Lee4, H Y Shin2, S M Kim2, K D Park1, S-V Yim4, J H Lee4, Y-C Choi2.   

Abstract

Inherited muscular disorders (IMDs) are clinically and genetically heterogeneous genetic disorders. We investigated the mutational spectrum and genotype-phenotype correlations in Korean patients with IMD. We developed a targeted panel of 69 known IMD genes and recruited a total of 209 Korean patients with IMD. Targeted capture sequencing identified 994 different variants. Among them, 98 variants were classified as pathogenic/likely pathogenic variants; 38 were novel variations. A total of 39 patients had the pathogenic/likely pathogenic variants. Among them, 75 (36%) patients were genetically confirmed, and 18 (9%) patients had one heterozygous variant of recessive myopathy. However, two genetically confirmed patients had an additional heterozygous variant of another recessive myopathy. Four patients with one heterozygous variant of a recessive myopathy showed different phenotypes, compared with the known phenotype of the identified gene. The major causative genes of Korean patients with IMDs were DMD (19 patients), COL6A1 (9), DYSF (9), GNE (7), LMNA (7), CAPN3 (6), and RYR1 (5). This study showed the mutational and clinical spectra in Korean patients with IMD and confirmed the usefulness of strategies utilizing targeted sequencing.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis; genotype-phenotype correlation; inherited muscular disorder; pathogenic variant; targeted sequencing

Mesh:

Year:  2016        PMID: 27363342     DOI: 10.1111/cge.12826

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

Review 1.  GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges.

Authors:  Nuria Carrillo; May C Malicdan; Marjan Huizing
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

2.  Clinical and Pathological Findings of a Korean Family with Pathogenic Variants of the TTN Gene.

Authors:  Hyung Jun Park; Jung Hwan Lee; Se Hoon Kim; Ji Man Hong; Ha Young Shin; Seung Min Kim; Ji Hyun Lee; Kee Duk Park; Young Chul Choi
Journal:  J Clin Neurol       Date:  2016-11-17       Impact factor: 3.077

3.  Clinical and Pathologic Findings of Korean Patients with RYR1-Related Congenital Myopathy.

Authors:  Ha Neul Jeong; Hyung Jun Park; Jung Hwan Lee; Ha Young Shin; Se Hoon Kim; Seung Min Kim; Young Chul Choi
Journal:  J Clin Neurol       Date:  2018-01       Impact factor: 3.077

4.  Clinical, Pathologic, and Genetic Features of Collagen VI-Related Myopathy in Korea.

Authors:  Jung Hwan Lee; Ha Young Shin; Hyung Jun Park; Se Hoon Kim; Seung Min Kim; Young Chul Choi
Journal:  J Clin Neurol       Date:  2017-08-01       Impact factor: 3.077

5.  Diagnostic yield of exome sequencing in myopathies: Experience of a Slovenian tertiary centre.

Authors:  Ivana Babić Božović; Aleš Maver; Lea Leonardis; Marija Meznaric; Damjan Osredkar; Borut Peterlin
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

6.  Early-Onset LMNA-Associated Muscular Dystrophy with Later Involvement of Contracture.

Authors:  Younggun Lee; Jung Hwan Lee; Hyung Jun Park; Young Chul Choi
Journal:  J Clin Neurol       Date:  2017-10       Impact factor: 3.077

7.  Genetically confirmed limb-girdle muscular dystrophy type 2B with DYSF mutation using gene panel sequencing: A case report.

Authors:  Sook Joung Lee; Eunseok Choi; Soyoung Shin; Joonhong Park
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

8.  Molecular diagnosis of muscular diseases in outpatient clinics: A Canadian perspective.

Authors:  Fanny Thuriot; Elaine Gravel; Caroline Buote; Marianne Doyon; Elvy Lapointe; Lydia Marcoux; Sandrine Larue; Amélie Nadeau; Sébastien Chénier; Paula J Waters; Pierre-Étienne Jacques; Serge Gravel; Sébastien Lévesque
Journal:  Neurol Genet       Date:  2020-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.